Smith & Nephew SNATS Inc ADR (SNN)
Smith & Nephew SNATS Inc ADR is a depositary receipt listed on the NYSE that represents common stock of Smith & Nephew plc. The underlying issuer is a healthcare company that develops, manufactures, markets, and sells medical devices and related services in the United Kingdom, the United States, and international markets. Its business is organized into three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
The Orthopaedics segment includes knee and hip implants, as well as trauma, extremities, and other reconstruction products. Sports Medicine & ENT covers products and technologies used in minimally invasive procedures, soft tissue repair, arthroscopic visualization, and ear, nose, and throat care. Advanced Wound Management provides products and technologies for acute and chronic wound treatment, including negative pressure wound therapy, bioactives, regenerative medicine products, and hydrosurgery systems. The company serves healthcare providers and is headquartered in Watford, United Kingdom.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-SNN
|
$39.42
|
26.0% Upside
|
Undervalued
|
$33.19
|
6.1% Upside
|
Fair
|
Great
|
2.5%
|
March 1, 2027
|
20.5x
|
2.5x
|
2.1x
|
13.013 B
|
16.044 B
|
22.6%
|
99.0%
|
10.0
|
52.4%
|
134.6%
|